BioMarin Pharmaceuticals, Inc. (BMRN) Tops Q2 EPS by 13c

July 25, 2013 4:23 PM

BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) reported Q2 EPS of ($0.16) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found